Clone-SwingTradeNov2023

The chart shows the growth of an initial investment of $10,000 in Clone-SwingTradeNov2023, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Nov 11, 2022, Clone-SwingTradeNov2023's average daily return is +0.19%, while the average monthly return is +3.85%. At this rate, your investment would double in approximately 1.5 years.

Historically, 62% of months were positive and 38% were negative. The best month was Feb 2024 with a return of +26.3%, while the worst month was Mar 2025 at -8.8%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Clone-SwingTradeNov2023 closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +12.8%, while the worst single day was Apr 3, 2025 at -7.4%.

Clone-SwingTradeNov2023 has an annualized alpha of 24.69%, beta of 1.55, and R² of 0.67 versus S&P 500 Index. Calculated based on daily prices since November 11, 2022.

• This portfolio captured 276.23% of S&P 500 Index gains and 120.72% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• This portfolio generated an annualized alpha of 24.69% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• Beta of 1.55 means this portfolio moves significantly more than S&P 500 Index — expect amplified gains in rallies and amplified losses in downturns.

Clone-SwingTradeNov2023 has an expense ratio of 0.02%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Clone-SwingTradeNov2023 ranks 16 for risk / return — in the bottom 16% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Clone-SwingTradeNov2023 Sharpe ratios as of Apr 4, 2026 (values are recalculated daily):

• 1-Year: 0.67
• All Time: 1.88

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.99 to 1.69, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Clone-SwingTradeNov2023 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Clone-SwingTradeNov2023 provided a 0.31% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Clone-SwingTradeNov2023. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Clone-SwingTradeNov2023 was 27.92%, occurring on Apr 8, 2025. Recovery took 62 trading sessions.

The current Clone-SwingTradeNov2023 drawdown is 13.81%.

The chart below shows the rolling one-month volatility.